Cover Image
Market Research Report

Europe Infection Surveillance Solution Systems Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 904393
Published Content info 150 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Infection Surveillance Solution Systems Market: Industry Trends and Forecast to 2026
Published: July 1, 2019 Content info: 150 Pages
Description

Europe Infection Surveillance Solution Systems market is projected to register a steady CAGR in the forecast period 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Products (Software and Services), Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Central Line-Associated Bloodstream Infections (CLABSI), Catheter Associated Urinary Tract Infection (CAUTI) and others), End User (Hospitals, Long Term Care Facilities, Clinics, Ambulatory Surgical Centers, Academic Institutes, Others),, Country (Germany, France, U.K., Italy, Spain, Ireland, Austria, Belgium, Netherlands, Switzerland, Rest of Europe)

Some of the major factors contributing to the growth of the Europe infection surveillance solution systems market:

  • Improving healthcare infrastructure
  • Increasing government initiative in the healthcare industry

Market Players:

The key market players for Europe infection surveillance solution systems market are listed below:

  • BD
  • Cerner Corporation
  • Illumina, Inc.
  • RL Solutions
  • GOJO Industries, Inc.
  • S.C. Johnson & Son, Inc.
  • Baxter
  • Wolters Kluwer
  • Vigilanz Corporation
  • IBM Corporation
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR MARKET CHALLENGE MATRIX
  • 2.9 DBMR VENDOR SHARE ANALYSIS
  • 2.10 MULTIVARIATE MODELING
  • 2.11 PRODUCTS LIFELINE CURVE
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS)
    • 3.1.2 INCREASING HEALTHCARE EXPENDITURE
    • 3.1.3 GOVERNMENT POLICIES FOR PREVENTING HEALTH-ACQUIRED INFECTIONS (HAIS)
  • 3.2 RESTRAINTS
    • 3.2.1 HIGH COST OF SOFTWARE
    • 3.2.2 DEARTH OF SKILLED IT PROFESSIONALS IN THE HEALTHCARE INDUSTRY
  • 3.3 OPPORTUNITIES
    • 3.3.1 CLOUD-BASED SOFTWARE OFFERS SIGNIFICANT GROWTH OPPORTUNITIES
    • 3.3.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS ASIA-PACIFIC AND LATIN AMERICA
  • 3.4 CHALLENGE
    • 3.4.1 DATA SECURITY RISK

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS

  • 6.1 OVERVIEW
  • 6.2 SOFTWARE
    • 6.2.1 WEB BASED
    • 6.2.2 ON-PREMISE
  • 6.3 SERVICES
    • 6.3.1 TRAINING & CONSULTING SERVICES
    • 6.3.2 IMPLEMENTATION SERVICES
    • 6.3.3 PRODUCT SUPPORT & MAINTENANCE SERVICES

7 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE

  • 7.1 OVERVIEW
  • 7.2 SURGICAL SITE INFECTIONS (SSI)
  • 7.3 URINARY TRACT INFECTIONS (UTI)
  • 7.4 BLOOD STREAM INFECTIONS (BSI)
  • 7.5 CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)
  • 7.6 CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI)
  • 7.7 OTHERS

8 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
    • 8.2.1 LARGE HOSPITALS
    • 8.2.2 MEDIUM-SIZED HOSPITALS
    • 8.2.3 SMALL HOSPITALS
  • 8.3 CLINICS
  • 8.4 AMBULATORY SURGICAL CENTERS
  • 8.5 LONG TERM CARE FACILITIES
    • 8.5.1 NURSING HOMES
    • 8.5.2 HOMECARE AGENCIES & SERVICES
    • 8.5.3 ASSISTED LIVING FACILITIES
  • 8.6 ACADEMIC INSTITUTES
  • 8.7 OTHERS

9 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY GEOGRAPHY

  • 9.1 EUROPE
    • 9.1.1 GERMANY
    • 9.1.2 FRANCE
    • 9.1.3 U.K.
    • 9.1.4 ITALY
    • 9.1.5 SPAIN
    • 9.1.6 NETHERLANDS
    • 9.1.7 SWITZERLAND
    • 9.1.8 BELGIUM
    • 9.1.9 RUSSIA
    • 9.1.10 TURKEY
    • 9.1.11 REST OF EUROPE

10 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: EUROPE

11 SWOT ANALYSIS

  • 11.1 DATA BRIDGE MARKET RESEARCH ANALYSIS

12 COMPANY PROFILES

  • 12.1 WOLTERS KLUWER
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 REVENUE ANALYSIS
    • 12.1.3 COMPANY SHARE ANALYSIS
    • 12.1.4 PRODUCT PORTFOLIO
    • 12.1.5 RECENT DEVELOPMENTS
  • 12.2 BD
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENT

  • 12.3 ILLUMINA, INC.
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 REVENUE ANALYSIS
    • 12.3.3 COMPANY SHARE ANALYSIS
    • 12.3.4 PRODUCT PORTFOLIO
    • 12.3.5 RECENT DEVELOPMENTS
  • 12.4 CERNER CORPORATION
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 REVENUE ANALYSIS
    • 12.4.3 COMPANY SHARE ANALYSIS
    • 12.4.4 PRODUCT PORTFOLIO
    • 12.4.5 RECENT DEVELOPMENTS
  • 12.5 BAXTER
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 REVENUE ANALYSIS
    • 12.5.3 COMPANY SHARE ANALYSIS
    • 12.5.4 PRODUCT PORTFOLIO
    • 12.5.5 RECENT DEVELOPMENTS
  • 12.6 GOJO INDUSTRIES, INC.
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 PRODUCT PORTFOLIO
    • 12.6.3 RECENT DEVELOPMENT
  • 12.7 IBM CORPORATION
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 REVENUE ANALYSIS
    • 12.7.3 PRODUCT PORTFOLIO
    • 12.7.4 RECENT DEVELOPMENT
  • 12.8 RL SOLUTIONS
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 PRODUCT PORTFOLIO
    • 12.8.3 RECENT DEVELOPMENT
  • 12.9 S. C. JOHNSON & SON, INC.
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 PRODUCT PORTFOLIO
    • 12.9.3 RECENT DEVELOPMENT
  • 12.10 VIGILANZ CORPORATION
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 PRODUCT PORTFOLIO
    • 12.10.3 RECENT DEVELOPMENT

13 CONCLUSION

14 QUESTIONNAIRE

15 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 2 EUROPE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 3 EUROPE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 4 EUROPE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 5 EUROPE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 6 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 7 EUROPE SURGICAL SITE INFECTIONS (SSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET,BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 EUROPE URINARY TRACT INFECTIONS (UTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 EUROPE BLOOD STREAM INFECTIONS (BSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 EUROPE CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 11 EUROPE CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 EUROPE OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 13 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 14 EUROPE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 EUROPE HOSPITAL IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 16 EUROPE CLINICS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17 EUROPE AMBULATORY SURGICAL CENTERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 EUROPE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 EUROPE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 20 EUROPE ACADEMIC INSTITUTES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 EUROPE OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 22 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 23 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 24 EUROPE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 25 EUROPE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 26 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 27 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 28 EUROPE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 29 EUROPE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 30 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 31 GERMANY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 32 GERMANY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 33 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 34 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 35 GERMANY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 36 GERMANY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 37 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 38 FRANCE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 39 FRANCE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 40 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 41 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 42 FRANCE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 43 FRANCE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 44 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 45 U.K. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 46 U.K. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 47 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 48 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 49 U.K. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 50 U.K. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 51 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 52 ITALY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 53 ITALY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 54 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 55 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 56 ITALY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 57 ITALY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 58 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 59 SPAIN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 60 SPAIN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 61 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 62 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 63 SPAIN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 64 SPAIN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 65 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 66 NETHERLANDS SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 67 NETHERLANDS SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 68 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 69 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 70 NETHERLANDS HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 71 NETHERLANDS LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 72 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 73 SWITZERLAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 74 SWITZERLAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 75 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 76 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 77 SWITZERLAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 78 SWITZERLAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 79 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 80 BELGIUM SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 81 BELGIUM SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 82 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 83 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 84 BELGIUM HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 85 BELGIUM LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 86 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 87 RUSSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 88 RUSSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 89 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 90 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 91 RUSSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 92 RUSSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 93 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 94 TURKEY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
  • TABLE 95 TURKEY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
  • TABLE 96 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
  • TABLE 97 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 98 TURKEY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 99 TURKEY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 100 REST OF EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
  • FIGURE 2 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: EUROPE VS REGIONAL ANALYSIS
  • FIGURE 5 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: THE MARKET CHALLENGE MATRIX
  • FIGURE 9 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF THE EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
  • FIGURE 11 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2015 & 2016)
  • FIGURE 12 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
  • FIGURE 13 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS) AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 14 SOFTWARE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN 2019 & 2026
  • FIGURE 15 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS, 2018
  • FIGURE 16 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY INFECTION TYPE, 2018
  • FIGURE 17 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY END USER, 2018
  • FIGURE 18 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
  • FIGURE 19 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
  • FIGURE 20 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 21 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 22 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
  • FIGURE 23 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
Back to Top